Vaishali Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 499.79 million compared to INR 345.8 million a year ago. Revenue was INR 516.5 million compared to INR 361.28 million a year ago. Net income was INR 38.21 million compared to INR 24.95 million a year ago. Basic earnings per share from continuing operations was INR 3.62 compared to INR 2.37 a year ago. Diluted earnings per share from continuing operations was INR 3.62 compared to INR 2.37 a year ago.